Sercloremine, usually as a hydrochloride, is an experimental drug candidate under study as an antidepressant. This drug was developed by Novartis and is in Phase II clinical trials.
This page contains text from Wikipedia, the Free Encyclopedia -
http://en.wikipedia.org/wiki/Sercloremine
This article is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License, which means that you can copy and modify it as long as the entire work (including additions) remains under this license.
This article is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License, which means that you can copy and modify it as long as the entire work (including additions) remains under this license.
